AGIOS PHARMACEUTICALS, INC. Capital Expenditures Incurred but Not yet Paid
AGIOS PHARMACEUTICALS, INC. (AGIO) reported Capital Expenditures Incurred but Not yet Paid of $186.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2026-07-30
- AGIOS PHARMACEUTICALS, INC. capital expenditures incurred but not yet paid for the quarter ending 2026-06-30 was -$482.00K.
- AGIOS PHARMACEUTICALS, INC. capital expenditures incurred but not yet paid for the quarter ending 2026-03-31 was $668.00K, a 202.26% increase year-over-year.
- AGIOS PHARMACEUTICALS, INC. capital expenditures incurred but not yet paid for the quarter ending 2025-12-31 was -$53.00K, a 120.70% decline year-over-year.
- AGIOS PHARMACEUTICALS, INC. capital expenditures incurred but not yet paid for the quarter ending 2025-09-30 was $214.00K, a 1026.32% increase year-over-year.
- AGIOS PHARMACEUTICALS, INC. capital expenditures incurred but not yet paid for fiscal 2025 was $283.00K, a 10.73% decline from fiscal 2024.
- AGIOS PHARMACEUTICALS, INC. capital expenditures incurred but not yet paid for fiscal 2024 was $317.00K, a 476.36% increase from fiscal 2023.
- AGIOS PHARMACEUTICALS, INC. capital expenditures incurred but not yet paid for fiscal 2023 was $55.00K, a 65.19% decline from fiscal 2022.
- AGIOS PHARMACEUTICALS, INC. capital expenditures incurred but not yet paid for fiscal 2022 was $158.00K, a 90.58% decline from fiscal 2021.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 9 month | Capital Expenditures Incurred but Not yet Paid 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$482.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $186.00K 10-Q · filed 2026-07-30 | $133.00K derived: sum of 3 quarters · filed 2026-07-30 | $347.00K derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $668.00K 10-Q · filed 2026-04-29 | $615.00K derived: sum of 2 quarters · filed 2026-04-29 | $829.00K derived: sum of 3 quarters · filed 2026-04-29 | $730.00K derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | -$53.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $161.00K derived: sum of 2 quarters · filed 2026-02-12 | $62.00K derived: sum of 3 quarters · filed 2026-07-30 | $283.00K 10-K · filed 2026-02-12 |
| 2025-09-30 | $214.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $115.00K derived: sum of 2 quarters · filed 2026-07-30 | $336.00K 10-Q · filed 2025-10-30 | $592.00K derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | -$99.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $122.00K 10-Q · filed 2026-07-30 | $378.00K derived: sum of 3 quarters · filed 2026-07-30 | $397.00K derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $221.00K 10-Q · filed 2026-04-29 | $477.00K derived: sum of 2 quarters · filed 2026-04-29 | $496.00K derived: sum of 3 quarters · filed 2026-04-29 | $538.00K derived: sum of 4 quarters · filed 2026-04-29 |
| 2024-12-31 | $256.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $275.00K derived: sum of 2 quarters · filed 2026-02-12 | $317.00K derived: sum of 3 quarters · filed 2026-02-12 | $317.00K 10-K · filed 2026-02-12 |
| 2024-09-30 | $19.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $61.00K derived: sum of 2 quarters · filed 2025-10-30 | $61.00K 10-Q · filed 2025-10-30 | $102.00K derived: sum of 4 quarters · filed 2026-02-12 |
| 2024-06-30 | $42.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $42.00K 10-Q · filed 2025-07-31 | $83.00K derived: sum of 3 quarters · filed 2026-02-12 | $91.00K derived: sum of 4 quarters · filed 2026-02-12 |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-01 | $41.00K derived: sum of 2 quarters · filed 2026-02-12 | $49.00K derived: sum of 3 quarters · filed 2026-02-12 | $55.00K derived: sum of 4 quarters · filed 2026-02-12 |
| 2023-12-31 | $41.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $49.00K derived: sum of 2 quarters · filed 2026-02-12 | $55.00K derived: sum of 3 quarters · filed 2026-02-12 | $55.00K 10-K · filed 2026-02-12 |
| 2023-09-30 | $8.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $14.00K derived: sum of 2 quarters · filed 2024-10-31 | $14.00K 10-Q · filed 2024-10-31 | $151.00K derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-06-30 | $6.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $6.00K 10-Q · filed 2024-08-01 | $143.00K derived: sum of 3 quarters · filed 2025-02-13 | $153.00K derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-04 | $137.00K derived: sum of 2 quarters · filed 2025-02-13 | $147.00K derived: sum of 3 quarters · filed 2025-02-13 | -$1.38M derived: sum of 4 quarters · filed 2025-02-13 |
| 2022-12-31 | $137.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $147.00K derived: sum of 2 quarters · filed 2025-02-13 | -$1.38M derived: sum of 3 quarters · filed 2025-02-13 | $158.00K 10-K · filed 2025-02-13 |
| 2022-09-30 | $10.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$1.51M derived: sum of 2 quarters · filed 2023-11-02 | $21.00K 10-Q · filed 2023-11-02 | $1.21M derived: sum of 4 quarters · filed 2024-02-15 |
| 2022-06-30 | -$1.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $11.00K 10-Q · filed 2023-08-03 | $1.20M derived: sum of 3 quarters · filed 2024-02-15 | $1.63M derived: sum of 4 quarters · filed 2024-02-15 |
| 2022-03-31 | $1.54M 10-Q · filed 2023-05-04 | $2.73M derived: sum of 2 quarters · filed 2024-02-15 | $3.16M derived: sum of 3 quarters · filed 2024-02-15 | $3.21M derived: sum of 4 quarters · filed 2024-02-15 |
| 2021-12-31 | $1.19M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | $1.62M derived: sum of 2 quarters · filed 2024-02-15 | $1.67M derived: sum of 3 quarters · filed 2024-02-15 | $1.68M 10-K · filed 2024-02-15 |
| 2021-09-30 | $430.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $480.00K derived: sum of 2 quarters · filed 2022-11-03 | $486.00K 10-Q · filed 2022-11-03 | $766.00K derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $50.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $56.00K 10-Q · filed 2022-08-04 | $336.00K derived: sum of 3 quarters · filed 2023-02-23 | -$3.10M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $6.00K 10-Q · filed 2022-05-05 | $286.00K derived: sum of 2 quarters · filed 2023-02-23 | -$3.15M derived: sum of 3 quarters · filed 2023-02-23 | -$4.97M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $280.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | -$3.16M derived: sum of 2 quarters · filed 2023-02-23 | -$4.98M derived: sum of 3 quarters · filed 2023-02-23 | $465.00K 10-K · filed 2023-02-23 |
| 2020-09-30 | -$3.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | -$5.26M derived: sum of 2 quarters · filed 2021-11-03 | $185.00K 10-Q · filed 2021-11-03 | $3.26M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | -$1.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | $3.62M 10-Q · filed 2021-07-29 | $6.70M derived: sum of 3 quarters · filed 2022-02-24 | $8.25M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $5.44M 10-Q · filed 2021-04-29 | $8.52M derived: sum of 2 quarters · filed 2022-02-24 | $10.08M derived: sum of 3 quarters · filed 2022-02-24 | $9.88M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $3.08M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $4.63M derived: sum of 2 quarters · filed 2022-02-24 | $4.44M derived: sum of 3 quarters · filed 2022-02-24 | $5.17M 10-K · filed 2022-02-24 |
| 2019-09-30 | $1.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $1.36M derived: sum of 2 quarters · filed 2020-11-05 | $2.09M 10-Q · filed 2020-11-05 | $2.69M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | -$192.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | $535.00K 10-Q · filed 2020-07-30 | $1.14M derived: sum of 3 quarters · filed 2021-02-25 | $276.00K derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $727.00K 10-Q · filed 2020-04-30 | $1.33M derived: sum of 2 quarters · filed 2021-02-25 | $468.00K derived: sum of 3 quarters · filed 2021-02-25 | $1.23M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $605.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$259.00K derived: sum of 2 quarters · filed 2021-02-25 | $501.00K derived: sum of 3 quarters · filed 2021-02-25 | $1.11M 10-K · filed 2021-02-25 |
| 2018-09-30 | -$864.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | -$104.00K derived: sum of 2 quarters · filed 2019-10-31 | $501.00K 10-Q · filed 2019-10-31 | $1.29M derived: sum of 4 quarters · filed 2020-02-19 |
| 2018-06-30 | $760.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $1.36M 10-Q · filed 2019-08-01 | $2.15M derived: sum of 3 quarters · filed 2020-02-19 | $993.00K derived: sum of 4 quarters · filed 2020-02-19 |
| 2018-03-31 | $605.00K 10-Q · filed 2019-05-02 | $1.39M derived: sum of 2 quarters · filed 2020-02-19 | $233.00K derived: sum of 3 quarters · filed 2020-02-19 | $1.40M derived: sum of 4 quarters · filed 2020-02-19 |
| 2017-12-31 | $785.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | -$372.00K derived: sum of 2 quarters · filed 2020-02-19 | $798.00K derived: sum of 3 quarters · filed 2020-02-19 | $1.01M 10-K · filed 2020-02-19 |
| 2017-09-30 | -$1.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $13.00K derived: sum of 2 quarters · filed 2018-11-01 | $226.00K 10-Q · filed 2018-11-01 | -$198.00K derived: sum of 4 quarters · filed 2019-02-14 |
| 2017-06-30 | $1.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $1.38M 10-Q · filed 2018-08-02 | $959.00K derived: sum of 3 quarters · filed 2019-02-14 | $96.00K derived: sum of 4 quarters · filed 2019-02-14 |
| 2017-03-31 | $213.00K 10-Q · filed 2018-05-04 | -$211.00K derived: sum of 2 quarters · filed 2019-02-14 | -$1.07M derived: sum of 3 quarters · filed 2019-02-14 | -$321.00K derived: sum of 4 quarters · filed 2019-02-14 |
| 2016-12-31 | -$424.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-14 | -$1.29M derived: sum of 2 quarters · filed 2019-02-14 | -$534.00K derived: sum of 3 quarters · filed 2019-02-14 | $73.00K 10-K · filed 2019-02-14 |
| 2016-09-30 | -$863.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | -$110.00K derived: sum of 2 quarters · filed 2017-11-01 | $497.00K 10-Q · filed 2017-11-01 | $1.58M derived: sum of 4 quarters · filed 2018-02-14 |
| 2016-06-30 | $753.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $1.36M 10-Q · filed 2017-08-08 | $2.44M derived: sum of 3 quarters · filed 2018-02-14 | $1.99M derived: sum of 4 quarters · filed 2018-02-14 |
| 2016-03-31 | $607.00K 10-Q · filed 2017-05-04 | $1.69M derived: sum of 2 quarters · filed 2018-02-14 | $1.24M derived: sum of 3 quarters · filed 2018-02-14 | -$3.83M derived: sum of 4 quarters · filed 2018-02-14 |
| 2015-12-31 | $1.08M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-14 | $632.00K derived: sum of 2 quarters · filed 2018-02-14 | -$4.44M derived: sum of 3 quarters · filed 2018-02-14 | $2.16M 10-K · filed 2018-02-14 |
| 2015-09-30 | -$451.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | -$5.52M derived: sum of 2 quarters · filed 2016-11-03 | $1.08M 10-Q · filed 2016-11-03 | $3.00M derived: sum of 4 quarters · filed 2017-02-16 |
| 2015-06-30 | -$5.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $1.53M 10-Q · filed 2016-08-08 | $3.45M derived: sum of 3 quarters · filed 2017-02-16 | $3.64M derived: sum of 4 quarters · filed 2017-02-16 |
| 2015-03-31 | $6.60M 10-Q · filed 2016-05-09 | $8.52M derived: sum of 2 quarters · filed 2017-02-16 | $8.71M derived: sum of 3 quarters · filed 2017-02-16 | $8.71M derived: sum of 4 quarters · filed 2017-02-16 |
| 2014-12-31 | $1.92M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-16 | $2.11M derived: sum of 2 quarters · filed 2017-02-16 | $2.10M derived: sum of 3 quarters · filed 2017-02-16 | $2.12M 10-K · filed 2017-02-16 |
| 2014-09-30 | $185.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $184.00K derived: sum of 2 quarters · filed 2015-11-06 | $197.00K 10-Q · filed 2015-11-06 | |
| 2014-06-30 | -$1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $12.00K 10-Q · filed 2015-08-07 | ||
| 2014-03-31 | $13.00K 10-Q · filed 2015-05-11 | |||
| 2013-12-31 | $339.00K 10-K · filed 2016-02-26 | |||
| 2012-12-31 | $57.00K 10-K · filed 2015-02-24 | |||
| 2011-12-31 | $275.00K 10-K · filed 2014-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |